Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries.
While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face.
1. Chapter 1. Introduction: Discovering Issues and Challenges in Low- and Middle-Income Countries - p. 1 2. Section 1. Sociobehavioral Aspects of Medicines use In low- and Middle-income Countries - p. 11 3. Chapter 2. Sociobehavioral Aspects of Medicines Use in Developing Countries - p. 15 4. Chapter 3. Patients’, Consumers’, and Healthcare Professionals’ Perceptions, Beliefs, Knowledge, Attitudes, and Practices Toward the Use of Medicines - p. 35 5. Chapter 4. The Use of Measurements and Health Behavioral Models to Improve Medication Adherence - p. 53 6. Section 2. Pharmaceutical Promotion In low- and Middle-income Countries - p. 69 7. Chapter 5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use, Impact, and Lessons Learned - p. 73 8. Section 3. Economic Evaluation and medicines Expenditure In low- and Middle-income Countries - p. 92 9. Chapter 6. Economic Evaluation and Medicines Expenditure in Developing Countries - p. 95 10. Chapter 7. Medicines Pricing Policy and Strategies in Developing Countries: A Review - p. 111 11. Chapter 8. Economic Evaluation of Predominant Disease in Developing Countries: Diabetes Mellitus - p. 129 12. Section 4. Pharmacovigilance and Patient safety In low- and Middle-income Countries - p. 142 13. Chapter 9. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction - p. 145 14. Chapter 10. Behavioral Aspects of Pharmacovigilance: Research Methods Considerations - p. 163 15. Chapter 11. Knowledge, Attitude, and Practice of Pharmacovigilance in Developing Countries - p. 177 16. Section 5. Generic Medicines use In low- and Middle-income Countries - p. 193 17. Chapter 12. Overcoming Challenges of Generic Medicines Utilization in Low- and Middle-Income Countries: Lessons Learned From International Experiences - p. 197 18. Chapter 13. Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets - p. 211 19. Section 6. Rational and Responsible Medicine use In low- and Middle-income Countries - p. 225 20. Chapter 14. Misconceptions and Misuse of Medicines in Developing Countries - p. 229 21. Chapter 15. Strengths and Weaknesses of Pharmaceutical Policy in Relation to Rational and Responsible Medicines Use - p. 247 22. Chapter 16. Rational and Responsible Medicines Use - p. 263 23. Section 7. Quality of Public health Pharmacy Services in Low- and Middle-income Countries - p. 277 24. Chapter 17. Quality of Pharmacy Health Services - p. 281 25. Chapter 18. Assessment of Medication Dispensing and Extended Community Pharmacy Services - p. 295 26. Chapter 19. Enhancing Quality of Patient-Centered Care Services in Developing Countries: Pharmaceutical Care Approach - p. 311 27. Chapter 20. Politics and Competition Between Professions: Future Scope of Pharmacy Practice - p. 329 28. Section 8. Medicine quality: Substandard and counterfeit Medicine in Low- and Middle-income Countries - p. 341 29. Chapter 21. Perspective, Knowledge, Attitude, and Belief of Various Stakeholders on Medicines Quality: Counterfeit and Substandard Medicines - p. 345 30. Section 9. Medicine Information and Health literacy In low- and Middle-income Countries - p. 360 31. Chapter 22. Issues on Source, Access, Extent, and Quality of Information Available Among Pharmacists and Pharmacy Personnel to Practice Effectively - p. 363 32. Section 10. Good Governance and Pharmaceutical Policy In low- and Middle-income Countries - p. 383 33. Chapter 23. Problems and Obstacles of Poorest Countries in Having Good Governance and Quality and Effective Pharmaceutical Policy - p. 387 34. Chapter 24. Pharmacogovernance: Advancing Pharmacovigilance and Patient Safety - p. 403 35. Chapter 25. Pharmaceutical Policy: Synthesis, Themes, and Future Directions - p. 419 36. Index - p. 439
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries.
While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face.
1. Chapter 1. Introduction: Discovering Issues and Challenges in Low- and Middle-Income Countries - p. 1 2. Section 1. Sociobehavioral Aspects of Medicines use In low- and Middle-income Countries - p. 11 3. Chapter 2. Sociobehavioral Aspects of Medicines Use in Developing Countries - p. 15 4. Chapter 3. Patients’, Consumers’, and Healthcare Professionals’ Perceptions, Beliefs, Knowledge, Attitudes, and Practices Toward the Use of Medicines - p. 35 5. Chapter 4. The Use of Measurements and Health Behavioral Models to Improve Medication Adherence - p. 53 6. Section 2. Pharmaceutical Promotion In low- and Middle-income Countries - p. 69 7. Chapter 5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use, Impact, and Lessons Learned - p. 73 8. Section 3. Economic Evaluation and medicines Expenditure In low- and Middle-income Countries - p. 92 9. Chapter 6. Economic Evaluation and Medicines Expenditure in Developing Countries - p. 95 10. Chapter 7. Medicines Pricing Policy and Strategies in Developing Countries: A Review - p. 111 11. Chapter 8. Economic Evaluation of Predominant Disease in Developing Countries: Diabetes Mellitus - p. 129 12. Section 4. Pharmacovigilance and Patient safety In low- and Middle-income Countries - p. 142 13. Chapter 9. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction - p. 145 14. Chapter 10. Behavioral Aspects of Pharmacovigilance: Research Methods Considerations - p. 163 15. Chapter 11. Knowledge, Attitude, and Practice of Pharmacovigilance in Developing Countries - p. 177 16. Section 5. Generic Medicines use In low- and Middle-income Countries - p. 193 17. Chapter 12. Overcoming Challenges of Generic Medicines Utilization in Low- and Middle-Income Countries: Lessons Learned From International Experiences - p. 197 18. Chapter 13. Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets - p. 211 19. Section 6. Rational and Responsible Medicine use In low- and Middle-income Countries - p. 225 20. Chapter 14. Misconceptions and Misuse of Medicines in Developing Countries - p. 229 21. Chapter 15. Strengths and Weaknesses of Pharmaceutical Policy in Relation to Rational and Responsible Medicines Use - p. 247 22. Chapter 16. Rational and Responsible Medicines Use - p. 263 23. Section 7. Quality of Public health Pharmacy Services in Low- and Middle-income Countries - p. 277 24. Chapter 17. Quality of Pharmacy Health Services - p. 281 25. Chapter 18. Assessment of Medication Dispensing and Extended Community Pharmacy Services - p. 295 26. Chapter 19. Enhancing Quality of Patient-Centered Care Services in Developing Countries: Pharmaceutical Care Approach - p. 311 27. Chapter 20. Politics and Competition Between Professions: Future Scope of Pharmacy Practice - p. 329 28. Section 8. Medicine quality: Substandard and counterfeit Medicine in Low- and Middle-income Countries - p. 341 29. Chapter 21. Perspective, Knowledge, Attitude, and Belief of Various Stakeholders on Medicines Quality: Counterfeit and Substandard Medicines - p. 345 30. Section 9. Medicine Information and Health literacy In low- and Middle-income Countries - p. 360 31. Chapter 22. Issues on Source, Access, Extent, and Quality of Information Available Among Pharmacists and Pharmacy Personnel to Practice Effectively - p. 363 32. Section 10. Good Governance and Pharmaceutical Policy In low- and Middle-income Countries - p. 383 33. Chapter 23. Problems and Obstacles of Poorest Countries in Having Good Governance and Quality and Effective Pharmaceutical Policy - p. 387 34. Chapter 24. Pharmacogovernance: Advancing Pharmacovigilance and Patient Safety - p. 403 35. Chapter 25. Pharmaceutical Policy: Synthesis, Themes, and Future Directions - p. 419 36. Index - p. 439
